BCM
BMY icon

Bienville Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bienville Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,110
Closed -$242K – 134
2020
Q2 		$242K Buy
+4,110
New +$246K 0.02% 119
2015
Q1 		– Sell
-14,000
Closed -$826K – 58
2014
Q4 		$826K Buy
+14,000
New +$790K 0.68% 26

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Bienville Capital Management's BMY Position: Q3 2020 in Review

Bienville Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 4,110 shares — an estimated $242K sold.

Bienville Capital Management first reported a position in BMY in Q4 2014 and held it in 2 quarters. The position peaked at $826K in Q4 2014. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Bienville Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
  • Bienville Capital Management sold 4,110 Bristol-Myers Squibb shares in Q3 2020, an estimated $242K.
  • Bienville Capital Management first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 2 quarters.
  • Bienville Capital Management's Bristol-Myers Squibb position peaked at $826K in Q4 2014.
  • 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Bienville Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.